Jul 29, 2021 / NTS GMT
Hiroshi Nomura - Sumitomo Dainippon Pharma Co., Ltd. - CEO, President & Representative Director
My name is Hiroshi Nomura. I'm the President and CEO of Sumitomo Dainippon Pharma. Thank you for taking your time to join the conference call for the first quarter. I would like to thank you for your continued interest in our company. Your comments and feedback are helpful in managing our company.
We published the financial results today. I personally wanted to be here to take your questions because I'm sure you have questions for me to explain the significant gaps in the results when you compare with the same period of last year, what was the forecast.
First, Mr. Kashima will go over the presentation.
Hisayoshi Kashima - Sumitomo Dainippon Pharma Co., Ltd. - Senior Director & Corporate Controller
Please look at Slide 3. I would like to present the financial results for the quarter on IFRS core basis. The revenues were JPY 131.2 billion, down by JPY 2.7 billion from the same period of last year. Although China segment increased revenues, Japan
Q1 2022 Sumitomo Dainippon Pharma Co Ltd Earnings Call Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers